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Objective: Non myeloablative conditioning regimen 
(NMCR) for AHSCT have been developed to reduce 
procedure-related toxicity. The aim of this approache is 
to extend indications of AHSCT to patients (pts) who 
are not eligible previously for high dose chemotherapy 
or total body irradiation. We describe infectious mor- 
bidity related to this new procedure in our unit in a 
retrospective study. 
Results: 45 AHSCT with NMCR were performed in our 
unit between 1997 to 2001,32 males, 13 females, with a 
median age of 48 years (range 18-62). Hematologic 
diagnosis were 8 AL, 12 MM, 2 CML, 5 NHL, 3 MDS, 6 
Hodgkin diseases, 3 CLL, 6 solid tumors. Engraftment 
was observed in all pts with a median of 21 days (range 
12119) for PNN >0.5 g/l, and 18 days (range O-201) for 
platelets >50 g/l. Ten pts received donor lymphocyte 
infusions (DLI). Nineteen pts (48.7%) presented acute 
GVHD: 7 without any DLI, 4 before DLI and 8 after 
DLI (2 grade 1,7 grade 2,4 grade 3 and 2 grade 4). 
Nineteen pts (42%) presented 39 infections : 1 episode, 
II = 7; 2 episodes, II = 7; 3 episodes, it = 3; 4 episodes, n= 1; 
5 episodes, y1= 1. Twenty two infections (56.5 %) occured 
in 13 pts during 3 months post transplant : 18 septi- 
cemia (12 Gram-negative bacilli, 5 Gram-positive cocci, 
one yeast), 1 septic chock without documentation, 2 
cytomegalovirus (CMV) infections, 1 zoster. Only 4 of 
these infections occured after engraftment (3 bacterial 
septicemia and 1 CMV disease). The pt with fungal 
septicemia died before engraftment. We observed 17 late 
infections (43.5%) in 11 pts : 3 septicemia, 1 septic chock 
without documentation, 2 CMV diseases, 6 probable 
invasive aspergillosis, 1 zoster, 1 Campylobacter colitis, 
1 Staphylococcus aureus pneumonia, 1 EBV lymphoma 
and 1 enterovirus encephalitis. Overall, bacterial in- 
fections were observed in 56% of cases, viral in 20% and 
fungal in 18%. No infection occured in 26 pts (58%). 
Five pts with hematologic malignancy relapse pre- 
sented a probable invasive aspergillosis. 
Twenty eight pts died (62%) 16 in relapse, 9 (32%) 
with infection : 1 fungal septicemia, 1 viral encephalitis, 
1 hepatitis, 6 invasive aspergillosis. 
Conclusion: Most of infections observed after AHSCT 
with NMCR were bacterial in our experience. 
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Aim: To describe the results of our strategies of pre- 
vention and treatment of infectious episodes during the 
neutropenic phase in HSCT Rc. 
Materials and methods : Total number of HSCT 417; 
number of patients (pts): 388; mean age: 33.9 (l-70); 
female: 256 (61%); hematological diseases: 247 (59%) 
solid tumors: 168 (40%) others 2; autologous (AU) 
314 (75%) allogeneic (AL) 103 (25%): related 89 (85%, 
haploidentical 3-2%) non-related 14 (13%): bone 
marrow 10, umbilical cord blood 4. Mean engraftment 
days: 12.8 (0-48).Weekly surveillance cultures (WSC) 
were done: anterior nares swab: detection (dt) of 
methicillin-resistant (R) Staphylococcus sp, penicillin-R 
pneumococci and Aspergillus sp, mouthwash: dt of 
Candida sp, penicillin-R Streptococcus sp and stool: dt 
of multidrug-R aerobic gram-negative bacilli (AGNB), 
vancomycin-R Enterococcus and Candida sp. Routinely 
selective gastrointestinal decontamination for AGNB 
and antifungal prophylaxis were not done. Fluconazol 
(FLU) was used only in pts with non-C. krusei colon- 
ization detected by WSC. The initial empirical treatment 
for neutropenia and fever was ceftazidime plus amikacin. 
The febrile episodes were defined according to the guide- 
lines of the Immunocompromised Host Society (1990). 
Results: 434 febrile episodes were detected: a) microbio- 
logically defined infection 150 (34.5%): mono or poly- 
microbial bacteremia (B) 63, fungemia (F) 2; site of 
infection (SI) with B 37 and with F 3; bacterial SI without 
B 55 and fungal SI without F 6; b) clinically defined 
infection 90 (21%) and c) possible infection 194 (45 %); 
there were 11 pts without fever. Isolated micro- 
organisms: 121 from 105 B and F,AGNB 52 (43%) with 
46 (85%) Enterobacteriaceae, gram-positive cocci 53 
(44%) with 41(77%) Staphylococcus sp, others 11(9%) 
and non-C. albicans 5 (4%). Nine pts had polymicrobial 
B and 7 more than one episode of B. The most frequent 
sites of infections with or without microbiological docu- 
mentation were: urinary tract 51(25%), lungs 48 (23%) 
skin and soft tissues 31 (15%) anal 25 (12%) and 
catheter 21 (lO%).Two hundred thirty colonized pts 
(55%) received FLU prophylaxis and 136 pts (33%) 
empirical amphotericin B (desoxycholate 119, liposomal 
28). Related transplant mortality was 10% (38/388), 
AU 8% (25/314), Al 13% (13003)and associated with 
documented infection 2% (7/388). 
Conclusions: (1) The use of FLU was avoided in 45 % of 
the pts, with the benefit of decreasing toxicity and costs. 
(2) All fungemias were by non-C.albicans, probably due 
to the previous overuse of FLU. (3) The same empirical 
antibiotic treatment has been used from the beginning 
of the program without emergence of R strains. (4) 
Mortality associated to documented infection was low, 
supporting our strategies of prevention and treatment. 
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Background: Transmission of bacterial infections from a 
donor to multiple recipients may occur in the setting of 
